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Cancer screening using acetic acid and visual inspection 
appears promising  
Can screening for cervical cancer — usually a complex, costly exercise — be made into a 
home-based test? A team of researchers spanning several Indian institutes have made firm 
steps towards realising this. 
“We intend to develop a calorimetric-based kit for cervical cancer detection. The ultimate 
goal is to develop an affordable and sensitive screening method which women could use 
themselves,” Dr. Aravind Kumar Rengan, Department of Biomedical Engineering, Indian 
Institute of Technology (IIT) Hyderabad, told The Hindu. 
A pap smear — a gold standard test — for cervical cancer screening may not be feasible in 
India due to inadequate infrastructure, lack of trained doctors, and the relatively high cost. On 
the other hand, say experts, cervical cancer screening using visual inspection with acetic acid 
(VIA) appears promising.  
A large clinical trial using VIA screening carried out by Dr. Surendra Sashtri and others from 
Mumbai’s Tata Memorial Centre, employed trained health workers, and showed the efficacy 
of the technique. More so, using acetic acid for cervical cancer screening is inexpensive and 
can reduce the lifetime risk of cervical cancer by nearly 25% to 36%. 
Currently, detection of cervical intraepithelial neoplasia (CIN) on application of acetic acid is 
through visual inspection. Therefore, it needs trained technicians.  
Dr. Rengan and his colleagues hope to do away with them. 
 
How it works 
Compared with normal epithelium, precancerous lesions contain an abnormally higher load 
of cellular proteins. Acetic acid applied on the cervix reacts with the proteins in precancerous 
lesions leading to protein coagulation. The protein coagulation appears opaque and white. 
Identifying the white patch can be tricky in some cases leading to reduced sensitivity of the 
VIA technique. 
More acetic acid gets used up when there is CIN and Dr. Rengan’s team is relying on the 
reduced amount of retrieved acetic acid for quantification. The acetic acid retrieved is made 
up to a fixed volume through the addition of reacting components such as gold chloride and 
other reactants. The reactants will form gold-based nanoparticles. Depending on the amount 
of retrieved acetic acid, the shape and size of the gold-based nanoparticles will vary resulting 
in difference in colour of the solution. 
Developing on this, the researchers aim to remove the flaws involved in the visual inspection 
method and make it more robust. “The visual method is currently a yes or no procedure. Our 
method will allow grading of the pre-cancerous lesions based on severity,” said Tejaswini 
Appidi from the Department of Biomedical Engineering, Indian Institute of Technology, 
Hyderabad. (She who won the BIRAC-SRISTI Gandhian Young Technological Innovation 
award for this innovation. The award comes with ₹15 lakh seed funding to develop a 
product.) 
The challenge will be to deliver acetic acid to the cervical site and recover the unused acetic 
acid. “In collaboration with Prof. Rohit Srivastava’s lab at IIT Bombay, we are developing a 
device that can directly deliver acetic acid to the site of cervix. We are in the process of filing 
a joint patent,” Dr. Rengan added. The team has developed the protocol and completed 
preliminary testing.  
They are in the process of tying up with hospitals to get clinical samples. “It will take two-
three years to develop the final product,” he says. 
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